Use a trendSingle weigh-ins can mislead
When the scale stops moving
Weight-loss plateau on Wegovy or Mounjaro
Two similar monthly weigh-ins do not automatically mean the medicine has failed. A doctor reviews the trend, waist, body composition, dose, adherence, nutrition, activity, sleep, side effects and medical factors before changing the plan.
Review the whole planDose is only one factor
Avoid extremesNo extra doses, crash diets or shortened intervals
The scales are only one measurement
Stable weight can hide changes in body composition
Why the number may stay the same
Starting resistance training can increase or preserve muscle while fat mass and waist size reduce. This does not explain every plateau, but it is one reason the clinical team should assess more than body weight.
Weight trendSame scale, similar time and conditionsWaist measurementMeasured consistently at agreed intervalsStrength and functionTraining performance and daily activityBody compositionUsed selectively when it changes decisions
Interval medical reviews01 02 03 04 05 06
The doctor identifies whether this is adaptation, body recomposition or loss of effect
Measurement quality
Compare like with like: the same scale, time of day, clothing and measurement technique. Look at several weeks, not one reading.
Dose and adherence
Confirm the prescribed strength, injection schedule, missed doses, pen technique and whether escalation is clinically appropriate.
Appetite and intake
Review hunger, food structure, protein, fibre, alcohol, liquid calories, eating outside meals and whether intake is sustainable rather than excessively low.
Activity and muscle
New resistance training, activity changes and muscle preservation can change how weight, waist and body composition move together.
Symptoms and recovery
Constipation, hydration, sleep, stress, menstrual cycle, menopause and recovery from training can influence the short-term trend.
Medical contributors
When indicated, review thyroid or metabolic disease, diabetes, mood, sleep disorders and medicines associated with weight change.
Confirm the trend
Use consistent weight and waist records over an appropriate interval. Travel, constipation, salt, hydration and different scales can create temporary changes.
Review with the doctor
Bring the dose history, injection dates, side effects, appetite changes, eating pattern, activity plan and measurements. The clinician decides whether more information or tests are needed.
Adjust one safe plan
The answer may be to continue, refine habits, address side effects, improve resistance training, investigate another factor or reconsider treatment. A higher dose is not automatic.
!
Safety first
Never take extra injections or shorten the interval
Trying to overcome a plateau by injecting early, combining products or increasing the dose without a prescription increases the risk of side effects and does not create a safe treatment plan.
Call 112 for a life-threatening emergency.
Common questions
Weight-loss plateau: questions
How long before stable weight counts as a plateau?
There is no universal definition. The doctor reviews a consistent trend over several weeks or months rather than a few days or two isolated weigh-ins.
Can gaining muscle hide fat loss on the scales?
It can partly mask the scale change, particularly after starting resistance training. Waist measurements, strength, clothing fit and body-composition assessment can add useful context.
Should my dose always increase during a plateau?
No. Dose escalation depends on the medicine's schedule, tolerability, current dose, indication and overall clinical assessment.
Can constipation or fluid changes hide progress?
Yes. Constipation, salt intake, hydration, menstrual cycle, travel and scale differences can temporarily affect body weight.
Does a plateau mean the medicine has stopped working?
Not necessarily. Weight loss commonly slows, and the doctor must review appetite, measurements, adherence, body composition and medical factors before deciding.
Can I take the injection early to break a plateau?
No. Never shorten the prescribed interval or take extra medicine. This increases risk and is not a safe plateau strategy.
What medical causes may need review?
Depending on symptoms and history, the clinician may review thyroid disease, diabetes, sleep, mood, menopause, medicines associated with weight change and other conditions.
When should treatment be reconsidered?
At scheduled reviews the clinician assesses benefit, adherence, tolerability, safety and whether treatment goals remain realistic. A plateau alone does not determine the decision.
Clinical sources: STEP 1 — semaglutide body composition · SURMOUNT-1 — tirzepatide body composition · EMA — Wegovy · EMA — Mounjaro. Individual assessment is required; body-composition results from substudies cannot diagnose the cause of one person’s plateau.
Medically reviewed
Dr Ben Harry Clegg
General practitioner · Málaga registration 292911940 · Nerja Medical Center NICA 55712
Clinical review date: 9 August 2026
Meet the telehealth medical team